Patent Assignment
Reel/Frame 021707/0639
Assignment of Assignor's Interest
Recorded: 2008-10-16
Pages: 16
Assignors
CHEN, WEIRONG
Executed: 2008-07-10
FRANKLIN, LLOYD
Executed: 2008-07-10
GUAN, BING
Executed: 2008-07-10
JONES, JOHN HOWARD
Executed: 2008-07-10
KUMARAVEL, GNANASAMBANDAM
Executed: 2008-07-10
LANE, BENJAMIN
Executed: 2008-07-10
LITTKE, ADAM
Executed: 2008-07-10
LUGOVSKOY, ALEXEY
Executed: 2008-07-10
PENG, HAIRUO
Executed: 2008-07-10
POWELL, NOEL
Executed: 2008-07-10
VESSELS, JEFFREY
Executed: 2008-07-10
WYNN, THOMAS
Executed: 2008-07-10
XIN, ZHILI
Executed: 2008-07-10
Assignee
BIOGEN IDEC MA INC.
14 CAMBRIDGE CENTER, CAMBRIDGE, MASSACHUSETTS, 02142
Covered Property
(1)
Compounds Useful as Raf Kinase Inhibitors
Related Assignments
(9)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 16, 2008
From: COSSROW, JENNIFER; RAIMUNDO, BRIAN C.; TANAKA, HIROKO
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 021688/0887 →
Confirmation of Assignment-Joint Ownership Between Biogen Idec Ma Inc. and Sunesis Pharmaceuticals, Inc.
Jul 17, 2009
From: BIOGEN IDEC MA INC.; SUNESIS PHARMACEUTICALS, INC.
To: SUNESIS PHARMACEUTICALS, INC.; BIOGEN IDEC MA INC.
Reel/Frame 022974/0461 →
Confirmation of Assignment-Joint Ownership Between Biogen Idec Ma Inc. and Sunesis Pharmaceutcials, Inc.
Jul 17, 2009
From: SUNESIS PHARMACEUTICALS, INC.; BIOGEN IDEC MA INC.
To: SUNESIS PHARMACEUTICALS, INC.; BIOGEN IDEC MA INC.
Reel/Frame 022974/0444 →
Assignment of Assignor's Interest
Dec 23, 2011
From: BIOGEN IDEC MA INC.
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 027441/0954 →
Assignment of Assignor's Interest
Apr 1, 2020
From: MILLENNIUM PHARMACEUTICALS, INC.
To: DOT THERAPEUTICS-1, INC.
Reel/Frame 052288/0694 →
Merger
May 17, 2022
From: DOT THERAPEUTICS-2, INC.; DOT THERAPEUTICS-1, INC.
To: DAY ONE BIOPHARMACEUTICALS, INC.
Reel/Frame 059936/0096 →
Change of Name
Apr 14, 2023
From: SUNESIS PHARMACEUTICALS, INC.
To: VIRACTA THERAPEUTICS, INC.
Reel/Frame 063349/0100 →
Assignment of Assignor's Interest
Dec 3, 2024
From: VIRACTA THERAPEUTICS, INC.
To: XOMA (US) LLC
Reel/Frame 069474/0049 →
Security Interest
Jul 14, 2026
From: CYDEX PHARMACEUTICALS, INC.; LIGAND PHARMACEUTICALS INCORPORATED; METABASIS THERAPEUTICS, INC.; XOMA (US) LLC
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 075969/0966 →